Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lake

Showing results (271-280 of 283) with videos related to

Pageof 29
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 16, 2019
Evaluation of Age-Related Pyrethroid Pharmacokinetic Differences in Rats: Physiologically-Based Pharmacokinetic Model Development Using In Vitro Data and In Vitro to In Vivo ExtrapolationGina Song, Marjory Moreau, Alina Efremenko, et al.
Regulatory Toxicology and Pharmacology : RTP|June 18, 1998
Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?R C Cattley, J DeLuca, C Elcombe, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|February 1, 1996
Evidence of chemical stimulation of hepatic metabolism by an experimental acetanilide (FOE 5043) indirectly mediating reductions in circulating thyroid hormone levels in the male ratW R Christenson, B D Becker, B S Wahle, et al.
Toxicology and Applied Pharmacology|June 1, 1995
Extrathyroidally mediated changes in circulating thyroid hormone concentrations in the male rat following administration of an experimental oxyacetamide (FOE 5043)W R Christenson, B D Becker, H D Hoang, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 9, 2019
Development and Application of a Life-Stage Physiologically Based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in HumansPankajini Mallick, Marjory Moreau, Gina Song, et al.
Toxicology|August 30, 2019
Metazachlor: Mode of action analysis for rat liver tumour formation and human relevanceChristiane Wiemann, Manuela Goettel, Audrey Vardy, et al.
Toxicology and Applied Pharmacology|July 7, 1998
Urinary physiologic and chemical metabolic effects on the urothelial cytotoxicity and potential DNA adducts of o-phenylphenol in male ratsR A Smith, W R Christenson, M J Bartels, et al.
Oncogene|July 18, 2019
EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasisLechen Li, Amir H Ameri, Simeng Wang, et al.
Current Drug Metabolism|February 3, 2007
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liverZoe E Barter, Martin K Bayliss, Philip H Beaune, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 22, 2001
Carbamazepine: a 'blind' assessment of CVP-associated metabolism and interactions in human liver-derived in vitro systemsO Pelkonen, P Myllynen, P Taavitsainen, et al.
Pageof 29

Showing results (271-280 of 283) with videos related to

Sort By:
Pageof 29
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 16, 2019
Evaluation of Age-Related Pyrethroid Pharmacokinetic Differences in Rats: Physiologically-Based Pharmacokinetic Model Development Using In Vitro Data and In Vitro to In Vivo ExtrapolationGina Song, Marjory Moreau, Alina Efremenko, et al.
Regulatory Toxicology and Pharmacology : RTP|June 18, 1998
Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?R C Cattley, J DeLuca, C Elcombe, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|February 1, 1996
Evidence of chemical stimulation of hepatic metabolism by an experimental acetanilide (FOE 5043) indirectly mediating reductions in circulating thyroid hormone levels in the male ratW R Christenson, B D Becker, B S Wahle, et al.
Toxicology and Applied Pharmacology|June 1, 1995
Extrathyroidally mediated changes in circulating thyroid hormone concentrations in the male rat following administration of an experimental oxyacetamide (FOE 5043)W R Christenson, B D Becker, H D Hoang, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 9, 2019
Development and Application of a Life-Stage Physiologically Based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in HumansPankajini Mallick, Marjory Moreau, Gina Song, et al.
Toxicology|August 30, 2019
Metazachlor: Mode of action analysis for rat liver tumour formation and human relevanceChristiane Wiemann, Manuela Goettel, Audrey Vardy, et al.
Toxicology and Applied Pharmacology|July 7, 1998
Urinary physiologic and chemical metabolic effects on the urothelial cytotoxicity and potential DNA adducts of o-phenylphenol in male ratsR A Smith, W R Christenson, M J Bartels, et al.
Oncogene|July 18, 2019
EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasisLechen Li, Amir H Ameri, Simeng Wang, et al.
Current Drug Metabolism|February 3, 2007
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liverZoe E Barter, Martin K Bayliss, Philip H Beaune, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 22, 2001
Carbamazepine: a 'blind' assessment of CVP-associated metabolism and interactions in human liver-derived in vitro systemsO Pelkonen, P Myllynen, P Taavitsainen, et al.
Pageof 29